Alogliptin and Pioglitazone
Alogliptin
Alogliptin is a medication used for the treatment of type 2 diabetes. It belongs to the DPP-4 inhibitors class. It helps lower blood sugar levels by increasing insulin production and reducing glucose production by the liver.
Pioglitazone
Pioglitazone is an oral antidiabetic medication commonly prescribed for type 2 diabetes. It belongs to the thiazolidinedione class. It works by improving insulin sensitivity in the body's cells and reducing glucose production in the liver.
Combination Therapy
Alogliptin and Pioglitazone are sometimes prescribed together as a combination therapy for managing type 2 diabetes. This combination can target different aspects of blood sugar control.
Table: Dosage Information
| Medication | Dosage Strength | Recommended Dose |
|---|---|---|
| Alogliptin | 25 mg, 50 mg | Once daily before or after a meal |
| Pioglitazone | 15 mg, 30 mg, 45 mg | Usually taken once daily, with or without meals |
Side Effects
Both Alogliptin and Pioglitazone can have side effects. Common side effects may include weight gain, fluid retention, and potential risk of heart-related issues. Serious side effects should be discussed with a healthcare professional.
Disclaimer
This information is for educational purposes only and should not be considered medical advice. Consult a healthcare professional for personalized medical guidance.
